Tyra Biosciences (TYRA) Current Leases (2020 - 2026)
Tyra Biosciences' (TYRA) quarterly Current Leases came in at $488000.0 in Q1 2026, up 14.55% YoY from $426000.0 in Q1 2025, and up 3.39% on a QoQ basis from $472000.0 in Q4 2025.
Tyra Biosciences (TYRA) Current Leases (2020 - 2026) Analysis & Trends
Tyra Biosciences (TYRA) has 7 years of Current Leases data on file, last reported at $488000.0 in Q1 2026.
- Quarterly Current Leases rose 14.55% year-over-year to $488000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $488000.0 (up 14.55% YoY) and the FY2025 annual result came in at $472000.0, up 14.56% from the prior year.
- Current Leases improved to $488000.0 in Q1 2026, from $472000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $488000.0 in Q1 2026 to a low of $119000.0 in Q1 2022.
- A 5-year average of $298294.1 and a median of $370000.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases plunged 30.69% — and 2024, when it soared 168.92%.
- Tracing TYRA's Current Leases over 5 years: stood at $140000.0 in 2022, then surged by 100.0% to $280000.0 in 2023, then surged by 47.14% to $412000.0 in 2024, then advanced by 14.56% to $472000.0 in 2025, then rose by 3.39% to $488000.0 in 2026.
- The last three Current Leases figures came in at $488000.0 (Q1 2026), $472000.0 (Q4 2025), and $456000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Tyra Biosciences | 1.51 Bn | 1.51 Bn | - | 504,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 504,000.00 |
| Mar 31, 2026 | 488,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Sep 30, 2025 | 456,000.00 |
| Jun 30, 2025 | 441,000.00 |
| Mar 31, 2025 | 426,000.00 |
| Dec 31, 2024 | 412,000.00 |
| Sep 30, 2024 | 398,000.00 |
| Jun 30, 2024 | 383,000.00 |
| Mar 31, 2024 | 370,000.00 |
| Dec 31, 2023 | 280,000.00 |
| Sep 30, 2023 | 148,000.00 |
| Jun 30, 2023 | 144,000.00 |
| Mar 31, 2023 | 144,000.00 |
| Dec 31, 2022 | 140,000.00 |
| Sep 30, 2022 | 127,000.00 |
| Jun 30, 2022 | 123,000.00 |
| Mar 31, 2022 | 119,000.00 |
| Dec 31, 2021 | 202,000.00 |
| Sep 30, 2021 | 135,000.00 |